ReShape Lifesciences Relocates Headquarters

Ticker: HIND · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1427570

Reshape Lifesciences Inc. 8-K Filing Summary
FieldDetail
CompanyReshape Lifesciences Inc. (HIND)
Form Type8-K
Filed DateJun 9, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-action, filing-update

TL;DR

ReShape Lifesciences moved its HQ to Irvine, CA.

AI Summary

On June 9, 2025, ReShape Lifesciences Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 18 Technology Drive, Suite 110, Irvine, CA 92618. This move from their previous San Clemente address signifies a potential operational shift or expansion.

Why It Matters

A change in principal executive offices can signal strategic shifts, operational changes, or growth initiatives for the company.

Risk Assessment

Risk Level: low — This filing is a routine administrative update regarding the company's address and does not contain information about significant financial or operational changes.

Key Players & Entities

  • ReShape Lifesciences Inc. (company) — Registrant
  • June 9, 2025 (date) — Date of earliest event reported
  • 18 Technology Drive, Suite 110 Irvine, CA 92618 (location) — New principal executive offices address
  • San Clemente, CA (location) — Previous principal executive offices address

FAQ

What is the new address for ReShape Lifesciences Inc.'s principal executive offices?

The new address for ReShape Lifesciences Inc.'s principal executive offices is 18 Technology Drive, Suite 110, Irvine, CA 92618.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on June 9, 2025.

What was the previous location of ReShape Lifesciences Inc.'s principal executive offices?

The previous location of ReShape Lifesciences Inc.'s principal executive offices was San Clemente, CA.

What is the Commission File Number for ReShape Lifesciences Inc.?

The Commission File Number for ReShape Lifesciences Inc. is 1-37897.

What is the Standard Industrial Classification code for ReShape Lifesciences Inc.?

The Standard Industrial Classification code for ReShape Lifesciences Inc. is 2834 (Pharmaceutical Preparations).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding ReShape Lifesciences Inc. (HIND).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.